2× more likely to respond
Across 19 randomized, double-blind, sham-controlled studies (854 participants for response), patients receiving rTMS were 2.25× as likely to achieve a treatment response as the comparison group. Across nine studies (551 participants), they were 2.78× as likely to achieve remission.
Vida RG, Sághy E, Bella R, et al. Efficacy of repetitive transcranial magnetic stimulation (rTMS) adjunctive therapy for major depressive disorder (MDD) after two antidepressant treatment failures: meta-analysis of randomized sham-controlled trials. BMC Psychiatry. 2023;23:545.

